secwatch.observer — SEC 8-K summary
======================================

Issuer:     Karyopharm Therapeutics Inc. (KPTI)
CIK:        0001503802
Form:       8-K
Filed at:   2023-12-08T23:59:59+00:00
Accession:  0001193125-23-291208
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Peter K. Honig resigns from Karyopharm board, effective Dec 31, 2023
-----------------------------------------------------------------------------

- Peter K. Honig, M.D., MPH, resigns from Board of Directors effective Dec 31, 2023.
- Departure due to competing professional demands; no disagreement with the Company.
- No replacement announced; resignation reduces board size.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1503802/000119312523291208/0001193125-23-291208-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1503802/000119312523291208/d614002d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-291208

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer